• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Ventana Medical Systems

Ventana Medical Systems

  1. The Collaborative Gene and Its Impact on Life Science Ecosystem Development: An Arizona Business Case

    The Collaborative Gene and Its Impact on Life Science Ecosystem Development: An Arizona Business Case

  2. AstraZeneca’s IMFINZI™ (durvalumab) Receives US FDA Accelerated Approval for Previously Treated Patients with Advanced Bladder Cancer

    AstraZeneca’s IMFINZI™ (durvalumab) Receives US FDA Accelerated Approval for Previously Treated Patients with Advanced Bladder Cancer

©2017 Morningstar Advisor. All right reserved.